Trending Now - Doctors Utilize Digital Twin to Address Patient's Heart Issue

WHO:

ABC News - Scientists at Johns Hopkins University created virtual replicas of patients’ hearts.

AP News - Dr. Jeffrey Goldberger, a heart specialist at the University of Miami, praised the findings.

AP News - Dr. Jonathan Chrispin, a Hopkins cardiologist and the study’s lead author, reported on the study's outcomes.

ABC News - Natalia Trayanova, a biomedical engineer at Johns Hopkins, is pioneering the digital twin technology.

WHAT:

ABC News - The study's results indicated that eight patients had no arrhythmias more than a year later, while two experienced only a single brief episode during their healing process.

AP News - The study's outcomes were reported to be better than the typical 60% success rate for the treatment of ventricular tachycardia.

ScienceAlert - The Hopkins team has begun a trial using the digital twin technology to treat atrial fibrillation, a more common type of irregular heartbeat.

ABC News - The study involved 10 patients and aimed to improve care for ventricular tachycardia, a major cause of sudden cardiac arrest.

AP News - The digital twin technology was allowed by the Food and Drug Administration to guide treatment for just 10 patients.

ABC News - The study reported that eight patients had no arrhythmias more than a year later, while two experienced only a single brief episode.

AP News - The typical success rate for the treatment is 60%, indicating the study's results were better than average.

ABC News - All but two patients stopped their anti-arrhythmia medication after treatment.

WHERE:

ABC News - The research was conducted at Johns Hopkins University in Washington, D.C.

WHEN:

ABC News - The results were reported on March 31st, 2026, in the New England Journal of Medicine.

AP News - The study was described as a small first step, indicating the need for larger studies in the future.

WHY:

ABC News - Ventricular tachycardia is a notoriously difficult-to-treat arrhythmia that is blamed for about 300,000 U.S. deaths a year.

AP News - The digital twin technology aims to improve treatment outcomes and reduce the trial-and-error nature of current ablation procedures.

HOW:

ABC News - The digital twin technology allows doctors to predict the best way to ablate by virtually ablating dysfunctional regions and observing the outcomes.

ABC News - The digital twin technology uses advanced MRI scans and other data to create interactive models of patients' hearts.

AP News - The technology allows doctors to predict how a real organ can react to different treatments by simulating the heart's electrical activity.

ABC News - Customized ablation targets were created for each of the 10 study participants, allowing cardiologists to aim specifically at those areas.

(UPDATED April 2, 2026 19:20 UTC)

A new study has shown promising results in treating ventricular tachycardia, with eight patients remaining free of arrhythmias more than a year later, while two had only a brief episode during their recovery. The outcomes from this study surpassed the typical success rate of sixty percent for this treatment. Additionally, the Hopkins team has initiated a trial using digital twin technology to address atrial fibrillation, which is a more common type of irregular heartbeat, allowing doctors to virtually ablate dysfunctional regions and predict the best treatment approaches.

--

(UPDATED April 2, 2026 11:15 UTC)

Scientists at Johns Hopkins University have developed virtual replicas of patients' hearts using advanced MRI scans and other data, aiming to improve care for ventricular tachycardia, a serious arrhythmia responsible for about 300,000 deaths in the U.S. each year. The study, which involved ten patients and was reported on Tuesday in the New England Journal of Medicine, showed promising results, with eight patients remaining free of arrhythmias over a year later, surpassing the typical success rate for such treatments. Dr. Jonathan Chrispin, the study's lead author, noted that this digital twin technology could help reduce the trial-and-error nature of current ablation procedures, paving the way for more effective treatments in the future.